AHR and obesity due to melanocortin 4 receptor deficiency: Another possibility, and one that is favored by our current data, is that an HFD-induced AHR agonist blocks preadipocytes from becoming thermogenically responsive adipocytes, thus decreasing energy expenditure and contributing to obesity.